NEW YORK Results from two clinical studies presented at this year’s American Headache Society meeting could help a needle-free migraine drug from Zogenix get Food and Drug Administration approval. The ...

Please provide your email address to receive an email when new articles are posted on . Adolescents with migraine were given lidocaine cream, lidocaine injections and saline injections. At 24 hours, ...

(Reuters) - Amgen Inc's push to get patients on its new $575 a month migraine drug before competition emerges in September is facing barriers from insurers. Bracing for a flood of costly prescription ...

Please provide your email address to receive an email when new articles are posted on . The study included 58 young persons with migraine flares lasting 24 hours to 3 months. A majority of those given ...

For millions of people with migraine, finding effective relief can be a frustrating journey marked by trial and error with various therapies. Hope may be on the ...

Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...

Senior Lecturer and Director of Headache Research, Consultant clinical scientist; King's College London and Guy's and St Thomas' NHS Trust, King's College London A drug that can help prevent migraines ...

Aeon Biopharma Inc.’s stock plunged 53% in intraday trading May 3 on the company’s announcement of disappointing results from testing of its migraine drug. The Irvine-based clinical-stage company ...

Migraines have been the bane of millions—debilitating, unpredictable, and extremely difficult to treat but a new challenger has entered the fray: a group of medications that have become synonymous ...

Excitement is mounting about a new class of drugs for migraine prevention. In one of the most recent developments, a new phase 2 trial of ALD403, a humanized monoclonal antibody directed against ...